Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin- vs cefuroxime-containing bismuth quadruple therapy for initial Helicobacter pylori eradication
ChiCTR-IPR-15006389Phase 4Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amoxicillin and cefuroxime in Helicobacter pylori infection (2 arms), sponsored by Peking University Third Hospital. Primary endpoint: Eradication rate. Planned start Jun 2015; status: not yet recruiting.
02
Drugs
amoxicillincefuroxime
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR-IPR-15006389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006389.